Andreas Pichlmair
Schneckenburger Str. 8
Munich, BY 81675, Germany
Munich, BY 81675, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Correction: RBM39 shapes innate immunity by controlling expression of key factors of the interferon response.
Journal: Frontiers in immunology
Published: January 06, 2026
Modanovo: A Unified Model for Post-translational Modification-Aware De Novo Sequencing Using Experimental Spectra From In Vivo and Synthetic Peptides.
Journal: Molecular & cellular proteomics : MCP
Published: September 16, 2025
LMP7 as a Target for Coronavirus Therapy: Inhibition by Ixazomib and Interaction with SARS-CoV-2 Proteins Nsp13 and Nsp16.
Journal: Pathogens (Basel, Switzerland)
Published: July 14, 2025
An ancient mitochondrial program tunes translation to haem availability.
Journal: Nature
Published: July 13, 2025
Elongator is required for pattern recognition receptor and type I interferon signaling in macrophages.
Journal: The Journal of biological chemistry
Published: June 10, 2025
HCR-Proxy resolves site-specific proximal RNA microenvironments at subcompartmental resolution.
Journal: Nucleic acids research
Published: May 27, 2025
Gasdermin E links tumor cell-intrinsic nucleic acid signaling to proinflammatory cell death for successful checkpoint inhibitor cancer immunotherapy.
Journal: Oncoimmunology
Published: May 14, 2025
TransFactor-prediction of pro-viral SARS-CoV-2 host factors using a protein language model.
Journal: Bioinformatics (Oxford, England)
Published: April 24, 2025
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response.
Journal: Frontiers in immunology
Published: January 28, 2025
Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients.
Journal: Breast cancer research : BCR
Published: January 14, 2025
Last Updated: 09/26/2026